These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 21646772

  • 1. [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].
    Minauchi K, Koizumi K, Kondo M, Takigami M, Harada H, Fujita H, Mukai M.
    Rinsho Ketsueki; 2011 May; 52(5):272-7. PubMed ID: 21646772
    [Abstract] [Full Text] [Related]

  • 2. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H, Izumoto S, Kinoshita M, Okita Y, Hashimoto N, Fujita T, Ichimaru N, Takahara S, Yoshimine T.
    Neurol Med Chir (Tokyo); 2010 May; 50(12):1079-83. PubMed ID: 21206182
    [Abstract] [Full Text] [Related]

  • 3. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS.
    Oncotarget; 2015 Oct 20; 6(32):33849-66. PubMed ID: 26460822
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
    Funch DP, Ko HH, Travasso J, Brady J, Kew CE, Nalesnik MA, Walker AM.
    Transplantation; 2005 Nov 15; 80(9):1174-80. PubMed ID: 16314782
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 15; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 6. Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.
    Muzaffar M, Taj A, Ratnam S.
    Am J Ther; 2010 Aug 15; 17(6):e230-3. PubMed ID: 19918163
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of monomorphic primary central nervous system post-transplantation lymphoproliferative disorder 5 years after kidney transplantation.
    Yaginuma T, Yamamoto H, Mitome J, Tanno Y, Yamamoto I, Kobayashi A, Mafune A, Hayakawa H, Yokoyama K, Mori R, Ohashi H, Kaito N, Joki T, Miki J, Yamada H, Furuta N, Matsushima S, Fukuda T, Hosoya T.
    Transpl Infect Dis; 2012 Oct 15; 14(5):E102-6. PubMed ID: 22931101
    [Abstract] [Full Text] [Related]

  • 8. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
    Langone A, Shihab F, Pankewycz O, Doria C, Wiland A, McCague K, Chan L.
    Clin Transplant; 2014 Sep 15; 28(9):961-7. PubMed ID: 24893821
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH.
    Pediatr Transplant; 2002 Oct 15; 6(5):396-9. PubMed ID: 12390426
    [Abstract] [Full Text] [Related]

  • 10. Albuminuria after renal transplantation: maintenance with sirolimus/low-dose tacrolimus vs. mycophenolate mofetil/high-dose tacrolimus.
    Miles CD, Skorupa JY, Sandoz JP, Rigley TH, Nielsen KJ, Stevens RB.
    Clin Transplant; 2011 Oct 15; 25(6):898-904. PubMed ID: 21077952
    [Abstract] [Full Text] [Related]

  • 11. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D.
    Transpl Int; 2005 Feb 15; 18(2):157-62. PubMed ID: 15691267
    [Abstract] [Full Text] [Related]

  • 12. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761
    [Abstract] [Full Text] [Related]

  • 13. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
    Khedmat H, Taheri S.
    Hematol Oncol Stem Cell Ther; 2011 Jan 15; 4(2):73-80. PubMed ID: 21727768
    [Abstract] [Full Text] [Related]

  • 14. Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.
    Steubl D, Baumann M, Schuster T, Fischereder M, Krämer BK, Heemann U, Lutz J.
    Scand J Urol Nephrol; 2012 Dec 15; 46(6):466-74. PubMed ID: 23016678
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
    Cullis B, D'Souza R, McCullagh P, Harries S, Nicholls A, Lee R, Bingham C.
    Am J Kidney Dis; 2006 May 15; 47(5):e67-72. PubMed ID: 16632009
    [Abstract] [Full Text] [Related]

  • 16. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov 15; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 17. Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation.
    Ekberg H, van Gelder T, Kaplan B, Bernasconi C.
    Transplantation; 2011 Jul 15; 92(1):82-7. PubMed ID: 21562449
    [Abstract] [Full Text] [Related]

  • 18. [Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report].
    Matsumoto K, Kobayashi T, Murakami K, Okubo K, Negoro H, Terada N, Sugino Y, Yamasaki T, Matsui Y, Inoue T, Kamba T, Yoshimura K, Ogawa O.
    Hinyokika Kiyo; 2014 Jun 15; 60(6):275-8. PubMed ID: 25001642
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
    Sun Q, Liu ZH, Yin G, Chen H, Chen J, Ji S, Li LS.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):510-7. PubMed ID: 16421166
    [Abstract] [Full Text] [Related]

  • 20. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.
    Exp Clin Transplant; 2008 Mar 15; 6(1):48-53. PubMed ID: 18405245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.